Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 652 | 32 | 265 | 242 | 323 |
| Receivables | 38 | 24 | 25 | 57 | 48 |
| Inventories | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $794 | $157 | $433 | $324 | $398 |
| Non-Current Assets | |||||
| PPE Net | 1,966 | 1,924 | 1,902 | 1,836 | 1,749 |
| Other Non-Current Assets | 14 | 14 | 14 | 14 | 14 |
| TOTAL | $1,980 | $1,938 | $1,916 | $1,850 | $1,763 |
| Total Assets | $2,774 | $2,095 | $2,349 | $2,174 | $2,160 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | 591 | 342 | 818 | 396 |
| TOTAL | $495 | $591 | $350 | $939 | $431 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26 | 26 | 26 | 26 | 26 |
| Other Non-Current Liabilities | 14 | 14 | 14 | 14 | 14 |
| TOTAL | $40 | $40 | $40 | $40 | $40 |
| Total Liabilities | $534 | $631 | $390 | $978 | $471 |
| Shareholders' Equity | |||||
| Common Shares | 8,684 | 7,552 | 7,505 | 6,314 | 6,304 |
| Retained earnings | -8,102 | -7,728 | -7,154 | -6,726 | -6,222 |
| TOTAL | $2,240 | $1,465 | $1,959 | $1,196 | $1,690 |
| Total Liabilities And Equity | $2,774 | $2,095 | $2,349 | $2,174 | $2,160 |